340 related articles for article (PubMed ID: 3087803)
21. Starvation decreases insulin secretion, prostaglandin E2 production and phospholipase A2 activity in rat pancreatic islets.
Tadayyon M; Bonney RC; Green IC
J Endocrinol; 1990 Mar; 124(3):455-61. PubMed ID: 2185328
[TBL] [Abstract][Full Text] [Related]
22. Carbachol stimulation of phospholipase A2 and insulin secretion in pancreatic islets.
Konrad RJ; Jolly YC; Major C; Wolf BA
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):283-90. PubMed ID: 1417779
[TBL] [Abstract][Full Text] [Related]
23. cPLA2alpha-evoked formation of arachidonic acid and lysophospholipids is required for exocytosis in mouse pancreatic beta-cells.
Juhl K; Høy M; Olsen HL; Bokvist K; Efanov AM; Hoffmann EK; Gromada J
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E73-81. PubMed ID: 12644445
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of insulin release by phospholipase D. A potential role for endogenous phosphatidic acid in pancreatic islet function.
Metz SA; Dunlop M
Biochem J; 1990 Sep; 270(2):427-35. PubMed ID: 2119172
[TBL] [Abstract][Full Text] [Related]
25. Is phospholipase A2 a "glucose sensor" responsible for the phasic pattern of insulin release?
Metz SA
Prostaglandins; 1984 Jan; 27(1):147-58. PubMed ID: 6424179
[TBL] [Abstract][Full Text] [Related]
26. Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells.
Kester M; Thomas CP; Wang J; Dunn MJ
J Cell Physiol; 1992 Nov; 153(2):244-55. PubMed ID: 1331121
[TBL] [Abstract][Full Text] [Related]
27. Lipoxygenase pathway in islet endocrine cells. Oxidative metabolism of arachidonic acid promotes insulin release.
Metz S; VanRollins M; Strife R; Fujimoto W; Robertson RP
J Clin Invest; 1983 May; 71(5):1191-205. PubMed ID: 6406544
[TBL] [Abstract][Full Text] [Related]
28. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
Svetlov SI; Howard KM; Miwa M; Flickinger BD; Olson MS
Arch Biochem Biophys; 1996 Mar; 327(1):113-22. PubMed ID: 8615681
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in beta-cell cytosolic calcium ion concentration.
Ramanadham S; Gross RW; Han X; Turk J
Biochemistry; 1993 Jan; 32(1):337-46. PubMed ID: 8418854
[TBL] [Abstract][Full Text] [Related]
30. Fatty acid incorporation into phospholipids of isolated pancreatic islets of the rat. Relationship to insulin release.
Laychock SG
Diabetes; 1983 Jan; 32(1):6-13. PubMed ID: 6336703
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic islet arachidonic acid turnover and metabolism and insulin release in response to delta-9-tetrahydrocannabinol.
Laychock SG; Hoffman JM; Meisel E; Bilgin S
Biochem Pharmacol; 1986 Jun; 35(12):2003-8. PubMed ID: 3013206
[TBL] [Abstract][Full Text] [Related]
32. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation.
Albert DH; Snyder F
J Biol Chem; 1983 Jan; 258(1):97-102. PubMed ID: 6401298
[TBL] [Abstract][Full Text] [Related]
33. A specific inhibitor of cytosolic phospholipase A2 activity, AACOCF3, inhibits glucose-induced insulin secretion from isolated rat islets.
Loweth AC; Scarpello JH; Morgan NG
Biochem Biophys Res Commun; 1996 Jan; 218(2):423-7. PubMed ID: 8561771
[TBL] [Abstract][Full Text] [Related]
34. Activity of endogenous phospholipase C and phospholipase A2 in glucose stimulated pancreatic islets.
Dunlop ME; Larkins RG
Biochem Biophys Res Commun; 1984 May; 120(3):820-7. PubMed ID: 6428399
[TBL] [Abstract][Full Text] [Related]
35. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
[TBL] [Abstract][Full Text] [Related]
36. Platelet-activating factor stimulates phospholipase in quiescent Swiss mouse 3T3 fibroblast.
Kawaguchi H; Yasuda H
FEBS Lett; 1984 Oct; 176(1):93-6. PubMed ID: 6436057
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological interference with phospholipase A2 activity reveals mechanistic differences between glucose and glyceraldehyde induced insulin release: implication for coupling of glucose metabolism to phospholipase A2 activity.
Tadayyon M; Green IC
Diabete Metab; 1993; 19(1):36-43. PubMed ID: 8504883
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
Bauldry SA; McCall CE; Cousart SL; Bass DA
J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
[TBL] [Abstract][Full Text] [Related]
39. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid.
Garcia MC; Fernandez-Gallardo S; Gijon MA; Garcia C; Nieto ML; Sanchez Crespo M
Biochem J; 1990 May; 268(1):91-8. PubMed ID: 1693077
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of lysophospholipids in intact rat islets. The insulin secretagogue p-hydroxymercuribenzoic acid impairs lysophosphatidylcholine catabolism and permits its accumulation.
Metz SA
Biochem J; 1987 Feb; 241(3):863-9. PubMed ID: 3297039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
